FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023304871> ?p ?o ?g. }

• W2023304871 endingPage "233" @default.
• W2023304871 startingPage "226" @default.
• W2023304871 abstract "Background and Objectives It has been recognized that inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX-2) produce important endogenous factors of human tumors such as nitric oxide (NO) and prostaglandins, which is involved in the process of carcinogenesis and tumor progression. This study aimed to evaluate the association of clinicopathologic factors, microvessel density, and patient survival with the expression of iNOS and COX-2 in patients with gastric adenocarcinoma. Materials and Methods Seventy-nine specimens, resected from patients with gastric adenocarcinoma, were investigated by immunohistochemical stain against iNOS and COX-2. Microvessels were stained using anti-CD34 antibody and counted as microvessel density. Results Positive iNOS and COX-2 expressions were significantly correlated with microvessel density by multivariate analysis, respectively (P = 0.0127 vs. P = 0.0214). There was significant difference among the four groups (both iNOS and COX-2 positive, iNOS positive only, COX-2 positive only, and both negative) in serosal invasion (P = 0.038), lymph node metastasis (P = 0.038), Helicobacter pylori infection (P = 0.025), vascular invasion (P = 0.035), and microvessel density (P = 0.019). In patients with gastric cancer that co-expressed iNOS and COX-2, prognosis was significantly poorer than in those that expressed either iNOS or COX-2, or did not express both of them (P = 0.01738). The Cox proportional hazard regression analysis indicated that iNOS expression, vascular invasion, serosal invasion, and microvessel density are independent prognostic factors for patients with gastric cancer. Conclusions iNOS and COX-2 expression of gastric cancer are related to tumor angiogenesis, tumor progression, and patient survival in human gastric cancer. J. Surg. Oncol. 2006;94:226–233. © 2006 Wiley-Liss, Inc." @default.
• W2023304871 created "2016-06-24" @default.
• W2023304871 creator A5017113195 @default.
• W2023304871 creator A5034080092 @default.
• W2023304871 creator A5041893129 @default.
• W2023304871 creator A5065316419 @default.
• W2023304871 creator A5085961965 @default.
• W2023304871 date "2006-01-01" @default.
• W2023304871 modified "2023-10-13" @default.
• W2023304871 title "Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer" @default.
• W2023304871 cites W1565050324 @default.
• W2023304871 cites W1605422292 @default.
• W2023304871 cites W1967243859 @default.
• W2023304871 cites W1973018387 @default.
• W2023304871 cites W1976887945 @default.
• W2023304871 cites W1982432279 @default.
• W2023304871 cites W1995348874 @default.
• W2023304871 cites W2000891017 @default.
• W2023304871 cites W2001580280 @default.
• W2023304871 cites W2003971447 @default.
• W2023304871 cites W2010618512 @default.
• W2023304871 cites W2012007418 @default.
• W2023304871 cites W2017564840 @default.
• W2023304871 cites W2018156866 @default.
• W2023304871 cites W2020638356 @default.
• W2023304871 cites W2021060079 @default.
• W2023304871 cites W2031203591 @default.
• W2023304871 cites W2033000482 @default.
• W2023304871 cites W2036800888 @default.
• W2023304871 cites W2043707891 @default.
• W2023304871 cites W2055354965 @default.
• W2023304871 cites W2058461395 @default.
• W2023304871 cites W2067429421 @default.
• W2023304871 cites W2077571136 @default.
• W2023304871 cites W2079494114 @default.
• W2023304871 cites W2082095075 @default.
• W2023304871 cites W2082424920 @default.
• W2023304871 cites W2097997344 @default.
• W2023304871 cites W2107665428 @default.
• W2023304871 cites W2125690417 @default.
• W2023304871 cites W2127558096 @default.
• W2023304871 cites W2149853739 @default.
• W2023304871 cites W2155199179 @default.
• W2023304871 cites W2158743409 @default.
• W2023304871 cites W2162110364 @default.
• W2023304871 cites W2216604643 @default.
• W2023304871 cites W2267519121 @default.
• W2023304871 cites W2324598964 @default.
• W2023304871 cites W2333908165 @default.
• W2023304871 cites W89794246 @default.
• W2023304871 doi "https://doi.org/10.1002/jso.20372" @default.
• W2023304871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16900533" @default.
• W2023304871 hasPublicationYear "2006" @default.
• W2023304871 type Work @default.
• W2023304871 sameAs 2023304871 @default.
• W2023304871 citedByCount "59" @default.
• W2023304871 countsByYear W20233048712012 @default.
• W2023304871 countsByYear W20233048712013 @default.
• W2023304871 countsByYear W20233048712014 @default.
• W2023304871 countsByYear W20233048712015 @default.
• W2023304871 countsByYear W20233048712016 @default.
• W2023304871 countsByYear W20233048712017 @default.
• W2023304871 countsByYear W20233048712018 @default.
• W2023304871 countsByYear W20233048712019 @default.
• W2023304871 countsByYear W20233048712020 @default.
• W2023304871 countsByYear W20233048712021 @default.
• W2023304871 countsByYear W20233048712022 @default.
• W2023304871 crossrefType "journal-article" @default.
• W2023304871 hasAuthorship W2023304871A5017113195 @default.
• W2023304871 hasAuthorship W2023304871A5034080092 @default.
• W2023304871 hasAuthorship W2023304871A5041893129 @default.
• W2023304871 hasAuthorship W2023304871A5065316419 @default.
• W2023304871 hasAuthorship W2023304871A5085961965 @default.
• W2023304871 hasConcept C121608353 @default.
• W2023304871 hasConcept C126322002 @default.
• W2023304871 hasConcept C142724271 @default.
• W2023304871 hasConcept C181199279 @default.
• W2023304871 hasConcept C204232928 @default.
• W2023304871 hasConcept C2776436680 @default.
• W2023304871 hasConcept C2777622882 @default.
• W2023304871 hasConcept C2779013556 @default.
• W2023304871 hasConcept C2779689624 @default.
• W2023304871 hasConcept C2780394083 @default.
• W2023304871 hasConcept C2781182431 @default.
• W2023304871 hasConcept C50382708 @default.
• W2023304871 hasConcept C519581460 @default.
• W2023304871 hasConcept C55493867 @default.
• W2023304871 hasConcept C71924100 @default.
• W2023304871 hasConcept C86803240 @default.
• W2023304871 hasConcept C90924648 @default.
• W2023304871 hasConceptScore W2023304871C121608353 @default.
• W2023304871 hasConceptScore W2023304871C126322002 @default.
• W2023304871 hasConceptScore W2023304871C142724271 @default.
• W2023304871 hasConceptScore W2023304871C181199279 @default.
• W2023304871 hasConceptScore W2023304871C204232928 @default.
• W2023304871 hasConceptScore W2023304871C2776436680 @default.
• W2023304871 hasConceptScore W2023304871C2777622882 @default.
• W2023304871 hasConceptScore W2023304871C2779013556 @default.

• next